Fujifilm Holdings is the biotechnology company most prolific at making international expansions, followed by Danaher and Beijing BGI-GBI Biotech. GlobalData’s biotechnology foreign direct investment (FDI) company report highlights the current foreign investments made by leading biotechnology investors. Buy the report here.

Fujifilm Holdings has been the most active biotechnology greenfield investor between Q1 2019 and Q4 2023, according to GlobalData’s FDI Projects Database. The Parent_clean company has been actively investing through several of its subsidiaries/company divisions.

Greenfield foreign direct investment is when a company invests abroad to establish a new physical presence or expand an existing operation. Greenfield investments create jobs and/or involve a capital investment into the foreign location. Other forms of FDI, such as mergers and acquisitions, are not included as part of this definition.

The majority of Fujifilm Holdings investments were in the genomics subsector. In fact, 20.8% of its total foreign investments were in this subsector. It also created projects across a further 14 subsectors.

By business function, most (49.1%) of Fujifilm Holdings projects were related to manufacturing. R&D and Healthcare provision were the next most popular operations undertaken by Fujifilm Holdings.

The company has been active across six world regions, mainly focused on North America which received 37.7% of the company’s greenfield investments between Q1 2019 and Q4 2023. Its top three destination countries (by number of greenfield FDI projects) were the US, the UK and India. Combined these three countries account for 170.6% of its total number of biotechnology investments.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Fujifilm Holdings created more FDI projects in 2021 compared to any other year between Q1 2019 and Q4 2023.

Other leading FDI project generators in the biotechnology industry include Danaher, Beijing BGI-GBI Biotech, C and Illumina.

The US is the leading source market for outbound biotechnology greenfield FDI projects. The country accounts for 29.3% of total outbound biotechnology investment projects. There have been 92 unique parent companies from the US that have announced biotechnology FDI projects between between Q1 2019 and Q4 2023.

To further understand the top biotechnology FDI companies, access GlobalData’s Top biotechnology Foreign Direct Investment Companies report.